SI3003286T1 - Postopek priprave trdnih nanodelcev z anorganskim oplaščenjem in njihova uporaba - Google Patents

Postopek priprave trdnih nanodelcev z anorganskim oplaščenjem in njihova uporaba

Info

Publication number
SI3003286T1
SI3003286T1 SI201431973T SI201431973T SI3003286T1 SI 3003286 T1 SI3003286 T1 SI 3003286T1 SI 201431973 T SI201431973 T SI 201431973T SI 201431973 T SI201431973 T SI 201431973T SI 3003286 T1 SI3003286 T1 SI 3003286T1
Authority
SI
Slovenia
Prior art keywords
inorganic coating
preparing solid
solid nanoparticles
nanoparticles
preparing
Prior art date
Application number
SI201431973T
Other languages
English (en)
Inventor
Jan-Otto Carlsson
Anders Johansson
Marten Rooth
Original Assignee
Nanexa Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48482962&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3003286(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nanexa Ab filed Critical Nanexa Ab
Publication of SI3003286T1 publication Critical patent/SI3003286T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/403—Oxides of aluminium, magnesium or beryllium
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30—Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40—Oxides
    • C23C16/405—Oxides of refractory metals or yttrium
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/4417—Methods specially adapted for coating powder
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/442—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating using fluidised bed process
    • C—CHEMISTRY; METALLURGY
    • C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/44—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
    • C23C16/455—Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into reaction chamber or for modifying gas flows in reaction chamber
    • C23C16/45523—Pulsed gas flow or change of composition over time
    • C23C16/45525—Atomic layer deposition [ALD]
    • C23C16/45555—Atomic layer deposition [ALD] applied in non-semiconductor technology

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Metallurgy (AREA)
  • Mechanical Engineering (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
SI201431973T 2013-05-24 2014-05-23 Postopek priprave trdnih nanodelcev z anorganskim oplaščenjem in njihova uporaba SI3003286T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13169219 2013-05-24
PCT/EP2014/060746 WO2014187995A1 (en) 2013-05-24 2014-05-23 A solid nanoparticle with inorganic coating
EP14725742.2A EP3003286B1 (en) 2013-05-24 2014-05-23 Method of preparing solid nanoparticles with inorganic coating and use thereof

Publications (1)

Publication Number Publication Date
SI3003286T1 true SI3003286T1 (sl) 2022-10-28

Family

ID=48482962

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431973T SI3003286T1 (sl) 2013-05-24 2014-05-23 Postopek priprave trdnih nanodelcev z anorganskim oplaščenjem in njihova uporaba

Country Status (18)

Country Link
US (7) US20160081945A1 (sl)
EP (2) EP4091606A1 (sl)
JP (2) JP6516729B2 (sl)
KR (2) KR102264011B1 (sl)
CN (2) CN113244192A (sl)
CA (1) CA2912697C (sl)
CY (1) CY1125419T1 (sl)
DK (1) DK3003286T3 (sl)
ES (1) ES2922465T3 (sl)
HR (1) HRP20220921T1 (sl)
HU (1) HUE059334T2 (sl)
LT (1) LT3003286T (sl)
PL (1) PL3003286T3 (sl)
PT (1) PT3003286T (sl)
RS (1) RS63496B1 (sl)
SI (1) SI3003286T1 (sl)
SM (1) SMT202200324T1 (sl)
WO (1) WO2014187995A1 (sl)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
KR102264011B1 (ko) 2013-05-24 2021-06-10 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자
EP3419659A1 (en) 2016-02-23 2019-01-02 The Regents of the University of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
CN108938592A (zh) * 2017-05-26 2018-12-07 武汉艾特米克超能新材料科技有限公司 一种低成本的药物包衣方法
WO2019010696A1 (en) * 2017-07-14 2019-01-17 General Electric Company METHOD FOR DEPOSITION LAYERED BY GAS PHASE MOLECULAR LAYER ON A MICROPOROUS SUPPORT
WO2019143744A1 (en) * 2018-01-16 2019-07-25 Applied Materials, Inc. Metal oxide encapsulated drug compositions and methods of preparing the same
US11180851B2 (en) 2018-06-12 2021-11-23 Applied Materials, Inc. Rotary reactor for uniform particle coating with thin films
KR102134793B1 (ko) * 2018-06-29 2020-07-16 주식회사 에프이엠 플렉시블 oled 터치구동용 투명전극 필름, 이의 제조방법 및 이를 이용한 터치패널
EP3824113A4 (en) 2018-07-19 2022-04-27 Applied Materials, Inc. Particle coating methods and apparatus
CN109512800A (zh) * 2019-01-18 2019-03-26 沈阳药科大学 一种载药氧化锌二氧化硅复合纳米粒的制备方法
TWI765795B (zh) 2019-04-24 2022-05-21 美商應用材料股份有限公司 具有旋轉葉片與氣體注入之用於在固定腔室中塗覆粒子的反應器
TWI732532B (zh) 2019-04-24 2021-07-01 美商應用材料股份有限公司 用於在具有旋轉槳的固定的腔室中塗覆顆粒的反應器
CN114007593A (zh) * 2019-04-26 2022-02-01 应用材料公司 包衣药物组成物及其制备方法
US11724340B2 (en) * 2019-05-23 2023-08-15 Saudi Arabian Oil Company Additive manufacturing of MLD-enhanced drilling tools
GB2585077A (en) * 2019-06-28 2020-12-30 Nanexa Ab Apparatus
WO2021039599A1 (ja) * 2019-08-23 2021-03-04 Ｊｘ金属株式会社 潜熱蓄熱材用マイクロカプセル及びその製造方法、並びに、潜熱蓄熱材用マイクロカプセルを含む粉末、及び当該粉末を含む蓄熱装置
TW202122111A (zh) * 2019-08-27 2021-06-16 美商應用材料股份有限公司 用於藥物溶解度控制之氣相塗層
KR20220051250A (ko) * 2019-08-27 2022-04-26 어플라이드 머티어리얼스, 인코포레이티드 약제 남용 억제 제형들을 위한 증기상 코팅 기술
KR20220110759A (ko) * 2019-12-06 2022-08-09 나넥사 에이비 신규 조성물
GB201917899D0 (en) * 2019-12-06 2020-01-22 Nanexa Ab New composition
GB202005593D0 (en) * 2020-04-17 2020-06-03 Nanexa Ab New composition
GB2594083A (en) * 2020-04-17 2021-10-20 Nanexa Ab New composition
TWI874667B (zh) 2020-06-05 2025-03-01 美商應用材料股份有限公司 經塗佈的藥物組成物及製備彼之方法
US12220678B2 (en) 2020-07-30 2025-02-11 Applied Materials, Inc. Paddle configuration for a particle coating reactor
TWI870622B (zh) * 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
GB202108305D0 (en) * 2021-06-10 2021-07-28 Nanexa Ab New process
EP4351530A1 (en) 2021-06-10 2024-04-17 Nanexa AB New formulations comprising azacitidine
EP4351527A1 (en) 2021-06-10 2024-04-17 Nanexa AB New composition comprising immunomodulatory drug
GB202108282D0 (en) * 2021-06-10 2021-07-28 Nanexa Ab New composition
WO2023056304A1 (en) 2021-09-30 2023-04-06 Applied Materials, Inc. Low temperature silicon oxide coating for pharmaceutical applications
US12697640B2 (en) 2021-10-22 2026-08-04 Applied Materials, Inc. Rotary reactor with drum for deposition of films onto particles
GB202117703D0 (en) 2021-12-08 2022-01-19 Nanexa Ab New composition
WO2023105227A1 (en) 2021-12-08 2023-06-15 Nanexa Ab New injectable combination formulation
WO2023215312A1 (en) * 2022-05-03 2023-11-09 Applied Materials, Inc. Drug compositions and methods of preparing the same
GB2619556A (en) 2022-06-10 2023-12-13 Nanexa Ab New process
WO2024033243A1 (en) 2022-08-10 2024-02-15 Basf Se Process for preparing coated organic particles
US20260041086A1 (en) 2022-08-10 2026-02-12 Basf Se Process for preparing coated organic particles
US20260043133A1 (en) 2022-08-10 2026-02-12 Basf Se Process for preparing coated organic particles
WO2024091652A1 (en) * 2022-10-28 2024-05-02 Applied Materials, Inc. Processes for preparing coated powder compositions
GB202218958D0 (en) 2022-12-15 2023-02-01 Nanexa Ab New pharmaceutical composition
AU2023392764A1 (en) 2022-12-15 2025-06-19 Nanexa Ab New pharmaceutical compositions comprising glucagon-like peptide-1 receptor agonists
WO2024249345A1 (en) * 2023-05-26 2024-12-05 Applied Materials, Inc. Preparation of pharmaceutical compositions using supercycle vapor phase deposition of inorganic oxides
WO2024256696A1 (en) 2023-06-15 2024-12-19 Nanexa Ab New injectable pharmaceutical depot compositions
WO2025096575A1 (en) * 2023-10-30 2025-05-08 Applied Materials, Inc. Methods for preparing drug containing particles enclosed by a laminated aluminum oxide and silicon oxide coating
WO2026012924A1 (en) 2024-07-09 2026-01-15 Basf Se Process for preparing coated organic particles

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753023A (en) * 1996-04-30 1998-05-19 Flex Products, Inc. Method for manufacture of small dimension product
US20020103467A1 (en) 2001-01-31 2002-08-01 Kubalak Thomas P. Urine collection bags for urinary catheter systems
TW200409669A (en) 2002-04-10 2004-06-16 Dow Corning Ireland Ltd Protective coating composition
WO2004083902A2 (en) * 2002-10-25 2004-09-30 Georgia Tech Research Corporation Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
CN1942173B (zh) * 2004-04-08 2012-05-09 协和发酵麒麟株式会社 稳定性提高的固体制剂及其制造方法
KR100859036B1 (ko) 2004-09-14 2008-09-17 씨디엠 옵틱스 인코퍼레이티드 촬상 시스템 및 관련 방법
US8097742B2 (en) 2005-01-20 2012-01-17 Agency For Science, Technology And Research Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling
US20070061006A1 (en) 2005-09-14 2007-03-15 Nathan Desatnik Methods of making shape memory films by chemical vapor deposition and shape memory devices made thereby
US7413982B2 (en) * 2006-03-29 2008-08-19 Eastman Kodak Company Process for atomic layer deposition
EP1891995A1 (en) 2006-08-08 2008-02-27 Debiotech S.A. Drug loading of porous coating
US20110104073A1 (en) * 2007-01-18 2011-05-05 Qi Zeng Iron/Iron Oxide Nanoparticle and Use Thereof
ES2763829T3 (es) 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
US7858144B2 (en) * 2007-09-26 2010-12-28 Eastman Kodak Company Process for depositing organic materials
US20090186086A1 (en) 2008-01-17 2009-07-23 Par Pharmaceutical, Inc. Solid multilayer oral dosage forms
US20090186068A1 (en) 2008-01-18 2009-07-23 Chameleon Scientific Corporation Atomic plasma deposited coatings for drug release
US20110054633A1 (en) 2008-01-18 2011-03-03 Nanosurface Technologies, Llc Nanofilm Protective and Release Matrices
CL2009000393A1 (es) 2008-02-21 2010-01-04 Duke Univ Y Immunolight Llc Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
JP5466379B2 (ja) 2008-06-30 2014-04-09 ツキオカフィルム製薬株式会社 フィルム状製剤及びフィルム状製剤の製造方法
JP2010059005A (ja) * 2008-09-02 2010-03-18 Kanazawa Inst Of Technology 複合体および複合体の製造方法
US8426489B1 (en) * 2008-12-15 2013-04-23 Stc.Unm Dental compositions based on nanocomposites for use in filling and dental crowns
JP2012514593A (ja) * 2009-01-05 2012-06-28 ゾル−ゲル テクノロジー リミテッド 被覆した活性剤を含む局所組成物
EP2429813B1 (en) * 2009-05-11 2018-06-13 The Regents of the University of Colorado, a Body Corporate Ultra-thin metal oxide and carbon-metal oxide films prepared by atomic layer deposition (ald)
US20110022160A1 (en) 2009-07-24 2011-01-27 Boston Scientific Scimed, Inc. Medical Devices Having an Inorganic Coating Layer Formed by Atomic Layer Deposition
JP2013510953A (ja) 2009-11-16 2013-03-28 ビーエーエスエフ ソシエタス・ヨーロピア 島状金属被覆及び合成方法
US20110229580A1 (en) * 2010-03-22 2011-09-22 Indian Institute of Technology Bombay, School of Biosciences and Bioengineering Compositions and methods for nano-in-micro particles
KR20140011358A (ko) 2011-03-03 2014-01-28 메르크 파텐트 게엠베하 코팅된 고형 약제학적 제제
TWI505524B (zh) * 2011-05-20 2015-10-21 Au Optronics Corp 有機電激發光光源
US9951419B2 (en) * 2011-09-03 2018-04-24 Ying-Bing JIANG Apparatus and method for making atomic layer deposition on fine powders
CN102330051A (zh) 2011-09-30 2012-01-25 中国科学院上海硅酸盐研究所 一种改善医用钛金属的抗菌性和生物活性的表面改性方法
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
KR102264011B1 (ko) 2013-05-24 2021-06-10 나넥사 에이비 무기성 코팅을 갖는 고형의 나노입자
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations

Also Published As

Publication number Publication date
US11717491B2 (en) 2023-08-08
CY1125419T1 (el) 2025-05-09
SMT202200324T1 (it) 2022-09-14
JP2019142913A (ja) 2019-08-29
EP4091606A1 (en) 2022-11-23
KR20210069740A (ko) 2021-06-11
US20260097001A1 (en) 2026-04-09
JP2016519155A (ja) 2016-06-30
CN113244192A (zh) 2021-08-13
US20210121415A1 (en) 2021-04-29
KR102371097B1 (ko) 2022-03-04
US10864171B2 (en) 2020-12-15
LT3003286T (lt) 2022-08-10
US10166198B2 (en) 2019-01-01
HUE059334T2 (hu) 2022-11-28
DK3003286T3 (da) 2022-07-25
US10478402B2 (en) 2019-11-19
KR102264011B1 (ko) 2021-06-10
RS63496B1 (sr) 2022-09-30
HRP20220921T1 (hr) 2022-10-28
PL3003286T3 (pl) 2022-10-10
KR20160013050A (ko) 2016-02-03
CA2912697C (en) 2022-11-08
CN105377244A (zh) 2016-03-02
EP3003286A1 (en) 2016-04-13
JP6516729B2 (ja) 2019-05-22
US12508236B2 (en) 2025-12-30
US20180221294A1 (en) 2018-08-09
US20160081945A1 (en) 2016-03-24
US20200108023A1 (en) 2020-04-09
CA2912697A1 (en) 2014-11-27
JP6772331B2 (ja) 2020-10-21
ES2922465T3 (es) 2022-09-15
WO2014187995A1 (en) 2014-11-27
CN105377244B (zh) 2021-05-04
US20180085321A1 (en) 2018-03-29
US20240000718A1 (en) 2024-01-04
PT3003286T (pt) 2022-07-22
EP3003286B1 (en) 2022-04-27

Similar Documents

Publication Publication Date Title
SMT202200324T1 (it) Procedimento per preparare nanoparticelle solide con rivestimento inorganico e loro uso
IL279767B (en) Medical polymeric nanoparticles, methods for their preparation and use
IL277633A (en) Antibodies and methods of use
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
GB2517079B (en) Security devices and methods of manufacture
IL244495B (en) Anti-alpha-synuclein antibodies and methods of use
GB201401762D0 (en) Security devices and methods of manufacture therof
GB201313363D0 (en) Security devices and method of manufacture
GB201401761D0 (en) Security devices and methods of manufacture thereof
GB2510381B (en) Security devices and methods of manufacture thereof
SG11201604763PA (en) Multilayered nanoparticle and methods of manufacturing and using the same
IL244643A0 (en) Anti-ly6e antibodies and methods of use
PT2994150T (pt) Probióticos e métodos de utilização
ZA201505825B (en) Coating compositions and methods of use
SG11201508944UA (en) Coating device and coating method
GB2515512B (en) Article and method of formation
GB201321848D0 (en) Lock means and method of use thereof
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof